{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:08:36Z","timestamp":1784833716404,"version":"3.55.0"},"reference-count":8,"publisher":"Sociedade Brasileira de Cardiologia","issue":"5","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Bras. Cardiol."],"DOI":"10.36660\/abc.20250832","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T18:55:17Z","timestamp":1784832917000},"source":"Crossref","is-referenced-by-count":0,"title":["Pistas Contradit\u00f3rias na Hipertrofia Ventricular Esquerda Grave: Uma Apresenta\u00e7\u00e3o Incomum de Amiloidose ATTR"],"prefix":"10.36660","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2817-190X","authenticated-orcid":false,"given":"Ana Sofia Nogueira","family":"Fernandes","sequence":"first","affiliation":[{"name":"Braga Local Health Unit,  Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Faria","sequence":"additional","affiliation":[{"name":"Braga Local Health Unit,  Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina Ferreira","family":"Vieira","sequence":"additional","affiliation":[{"name":"Braga Local Health Unit,  Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22636","published-online":{"date-parts":[[2026]]},"reference":[{"issue":"16","key":"ref1","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and Treatment of Cardiac Amyloidosis: A Position Statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia P","year":"2021","journal-title":"Eur Heart J"},{"issue":"11","key":"ref2","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient with Cardiac Amyloidosis: A Report of the American College of Cardiology Solution Set Oversight Committee","volume":"81","author":"Kittleson MM","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.36660\/abc.20210718","article-title":"Position Statement on Diagnosis and Treatment of Cardiac Amyloidosis - 2021","volume":"117","author":"Sim\u00f5es MV","year":"2021","journal-title":"Arq Bras Cardiol"},{"issue":"9","key":"ref4","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006075","article-title":"Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis","volume":"12","author":"Maurer MS","year":"2019","journal-title":"Circ Heart Fail"},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.3390\/biomedicines10123052","article-title":"Diagnostic Accuracy of Bone Scintigraphy for the Histopathological Diagnosis of Cardiac Transthyretin Amyloidosis-A Retrospective Austrian Multicenter Study","volume":"10","author":"Verheyen N","year":"2022","journal-title":"Biomedicines"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jcmg.2019.10.015","article-title":"Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis","volume":"13","author":"Musumeci MB","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"22","key":"ref7","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review","volume":"73","author":"Ruberg FL","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy","volume":"379","author":"Maurer MS","year":"2018","journal-title":"N Engl J Med"}],"container-title":["Arquivos Brasileiros de Cardiologia"],"original-title":["Conflicting Clues in Severe LV Hypertrophy: An Unusual Presentation of ATTR Amyloidosis"],"link":[{"URL":"https:\/\/abccardiol.org\/wp-content\/uploads\/articles_xml\/0066-782x-abc-123-5-e20250832\/0066-782x-abc-123-5-e20250832.x98474.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T18:55:19Z","timestamp":1784832919000},"score":1,"resource":{"primary":{"URL":"https:\/\/abccardiol.org\/article\/pistas-contraditorias-na-hipertrofia-ventricular-esquerda-grave-uma-apresentacao-incomum-de-amiloidose-attr\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":8,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026]]}},"alternative-id":["S0066-782X2026000501804"],"URL":"https:\/\/doi.org\/10.36660\/abc.20250832","relation":{"is-translation-of":[{"id-type":"doi","id":"10.36660\/abc.20250832i","asserted-by":"subject"},{"id-type":"doi","id":"10.36660\/abc.20250832i","asserted-by":"object"}]},"ISSN":["1678-4170","0066-782X"],"issn-type":[{"value":"1678-4170","type":"electronic"},{"value":"0066-782X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e20250832"}}